U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
  FAQs Site Map About MedelinePlus Contact Us
español
Reuters Health Information Logo

Long-term risks of Viagra use unclear

Printer-friendly version E-mail this page to a friend

Reuters Health

Thursday, October 8, 2009

NEW YORK (Reuters Health) - The popular erectile dysfunction drug Viagra is associated with a number of side effects, but data on long-term harms are still lacking, according to a review of 49 published studies.

In the medical journal Urology, Dr. Alexander Tsertsvadze, from Ottawa Health Research Institute, Ontario, Canada, and colleagues report that men who took Viagra, also known as sildenafil, were 56 percent more likely than those given a placebo to experience any side effect.

Specific side effects commonly reported by men using Viagra were headache, flushing difficulty breathing, and vision problems.

The results also show that the risk of these side effects increased as the dose of Viagra rose.

The researchers say more studies are needed with longer follow up, which did not exceed 12 weeks in the studies reviewed.

"More efforts should be directed toward achieving an optimal balance between the degree of effectiveness and safety of sildenafil use in men with erectile dysfunction," they conclude.

"For example, consideration of flexible dosing regimen of sildenafil to minimize the occurrence of adverse events may be an option," they wrote.

SOURCE: Urology, October 2009.


Reuters Health

© 2009 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

Related News:
More News on this Date

Related MedlinePlus Pages: